ADVENTRX Pharmaceuticals (ANX) Reports Q3 Loss of $0.07
Tweet
Share
E-mailGet Alerts ANX Hot Sheet
Price: $0.73 --0%
Financial Fact:
Loss from operations: -7.2M
Today's EPS Names:
VISL, GNLN, USDP, More
Financial Fact:
Loss from operations: -7.2M
Today's EPS Names:
VISL, GNLN, USDP, More
Join SI Premium – FREE
ADVENTRX Pharmaceuticals (NYSE: ANX) reported Q3 EPS of ($0.07), versus ($0.13) reported last year.
For earnings history and earnings-related data on ADVENTRX Pharmaceuticals (ANX) click here.
For earnings history and earnings-related data on ADVENTRX Pharmaceuticals (ANX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- L3Harris CEO steps down amid conduct review, shares drop
- Jasper Therapeutics (JSPR) Tops Q2 EPS by 18c
- Vislink Technologies Inc. (VISL) Misses Q2 EPS by 7c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
